DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Xeloda (Capecitabine) - News

 
 



News related to Xeloda (Capecitabine) and/or conditions it is approved for

Favorable OS rates for rectal cancer patients demonstrated by secondary analysis of RTOG 0247
Source: Radiology / Nuclear Medicine News From Medical News Today [2015.01.13]
Locally advanced rectal cancer patients who receive preoperative radiation therapy with either irinotecan plus capecitabine or oxaliplatin plus capecitabine have a four-year overall survival rate of...

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015